Перейти к информации о продукте
1 из 1

Mavixen (Glecaprevir 100 mg/Pibrentasvir 40 mg)

Mavixen (Glecaprevir 100 mg/Pibrentasvir 40 mg)

Просмотреть всю информацию
Strength: Glecaprevir 100 mg + Pibrentasvir 40 mg
Composition: Glecaprevir 100 mg / Pibrentasvir 40 mg
Treatment: Chronic Hepatitis C (HCV)
Brand: Mavixen
Manufacturer: Everest Pharmaceuticals Ltd.

Mavixen (Glecaprevir 100 mg/Pibrentasvir 40 mg) is a fixed-dose combination medicine manufactured by Everest Pharmaceuticals Ltd. It contains two direct-acting antiviral agents, Glecaprevir and Pibrentasvir, which work together to inhibit different proteins essential for hepatitis C virus (HCV) replication. Mavixen is used for the treatment of chronic hepatitis C infection across HCV genotypes 1–6, according to the approved indication and patient-specific medical assessment. Everest officially lists Mavixen under its Hepatitis product portfolio

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.